Cargando…
Adverse effects of salmeterol in asthma: a neuronal perspective
BACKGROUND: Regular use of inhaled β(2)-agonists has been associated with a paradoxical loss of asthma control and a deterioration of airway hyper-responsiveness, but the underlying mechanism is unknown. The neurotrophin brain-derived neurotrophic factor (BDNF) has recently been identified as a medi...
Autores principales: | Lommatzsch, M, Lindner, Y, Edner, A, Bratke, K, Kuepper, M, Virchow, J C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730557/ https://www.ncbi.nlm.nih.gov/pubmed/19237390 http://dx.doi.org/10.1136/thx.2008.110916 |
Ejemplares similares
-
Managing moderate-to-severe paediatric asthma: a scoping review of the efficacy and safety of fluticasone propionate/salmeterol
por: Pitrez, Paulo Marcio, et al.
Publicado: (2023) -
Reslizumab as add-on therapy in patients with refractory asthma
por: Virchow, J Christian, et al.
Publicado: (2020) -
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies
por: Chapman, Kenneth, et al.
Publicado: (2021) -
Adverse childhood experiences and asthma: trajectories in a national cohort
por: Pape, Kathrine, et al.
Publicado: (2021) -
Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review
por: Patel, Roshni, et al.
Publicado: (2020)